Interleukin (IL)‐17‐producing pathogenic T lymphocytes co‐express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study

Documenti analoghi

• T Regulatory and T Helper 17 Cells in Primary Sjögren’s Syndrome: Facts and Perspectives
  di: Alessia Alunno, et al.
  Pubblicazione: (2015-01-01)
• T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives
  di: Alunno, Alessia, et al.
  Pubblicazione: (2015)
• Interferon gamma-inducible protein 16 in primary Sjögren’s syndrome: a novel player in disease pathogenesis?
  di: Alunno, Alessia, et al.
  Pubblicazione: (2015)
• Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren’s syndrome: findings in serum and minor salivary glands
  di: A. Alunno, et al.
  Pubblicazione: (2016-02-01)
• IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren’s syndrome
  di: A. Alunno, et al.
  Pubblicazione: (2013-10-01)